Also known as: GSK189075
Sergliflozin Etabonate is a prodrug of the selective sodium-glucose cotransporter 2 (SGLT2) inhibitor Sergliflozin. By inhibiting SGLT2 in the kidneys, it reduces reabsorption of glucose and promotes urinary glucose excretion, thereby lowering blood glucose levels in type 2 diabetes. Mediocon Inc supplies high-purity Sergliflozin Etabonate API from its GMP-certified manufacturing plant in Aurangabad, Maharashtra.
| Parameter | Specification |
|---|---|
| CAS Number | 125926-17-2 |
| Molecular Formula | C₂₂H₂₅ClO₈ |
| Molecular Weight | 460.88 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Antidiabetic / SGLT2 Inhibitor |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Sergliflozin Etabonate — CAS 125926-17-2 (CAS 125926-17-2) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Sergliflozin Etabonate — CAS 125926-17-2 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance